Amgen Inc. (AMGN) Operating margin 2016–2025
Amgen Inc. (AMGN) operating margin by fiscal year — reported operating income divided by reported revenue.
24.7%FY2025 · since FY2016: 42.6% → 24.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 24.7% | +3.0 pp |
| FY2024 | 21.7% | -6.3 pp |
| FY2023 | 28.0% | -8.3 pp |
| FY2022 | 36.3% | +6.9 pp |
| FY2021 | 29.4% | -6.5 pp |
| FY2020 | 35.9% | -5.5 pp |
| FY2019 | 41.4% | -1.8 pp |
| FY2018 | 43.2% | -0.4 pp |
| FY2017 | 43.6% | +1.0 pp |
| FY2016 | 42.6% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More AMGN financial trends
AMGN RevenueAMGN Net incomeAMGN Net marginAMGN Gross profitAMGN Gross marginAMGN Operating incomeAMGN Operating cash flowAMGN Free cash flowAMGN Capital expendituresAMGN Return on equityAMGN Stock buybacksAMGN Dividends paidAMGN Total assetsAMGN Total liabilitiesAMGN Shareholders’ equityAMGN overview →